5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN

Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OZA, MRINALINI S, BRUCE, IAN, BLOOMFIELD, G. C, LEBLANC, CATHERINE, WHITEHEAD, LEWIS
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OZA, MRINALINI S
BRUCE, IAN
BLOOMFIELD, G. C
LEBLANC, CATHERINE
WHITEHEAD, LEWIS
description Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE602004011199TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE602004011199TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE602004011199TT23</originalsourceid><addsrcrecordid>eNrjZHA31Q3wcPWL9Anx8HSM8vdxcQ3yDHMMcVUI9XNRAHJc_RTCXIPCXf1cQv3cFRx9ghUCDI11vT39HINddT39PDydPEP8gap4GFjTEnOKU3mhNDeDmptriLOHbmpBfnxqcUFicmpeakm8i6uZgZGBgYmBoaGhpWVIiJEx0QoBq_Iu-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN</title><source>esp@cenet</source><creator>OZA, MRINALINI S ; BRUCE, IAN ; BLOOMFIELD, G. C ; LEBLANC, CATHERINE ; WHITEHEAD, LEWIS</creator><creatorcontrib>OZA, MRINALINI S ; BRUCE, IAN ; BLOOMFIELD, G. C ; LEBLANC, CATHERINE ; WHITEHEAD, LEWIS</creatorcontrib><description>Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><language>ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090102&amp;DB=EPODOC&amp;CC=DE&amp;NR=602004011199T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090102&amp;DB=EPODOC&amp;CC=DE&amp;NR=602004011199T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OZA, MRINALINI S</creatorcontrib><creatorcontrib>BRUCE, IAN</creatorcontrib><creatorcontrib>BLOOMFIELD, G. C</creatorcontrib><creatorcontrib>LEBLANC, CATHERINE</creatorcontrib><creatorcontrib>WHITEHEAD, LEWIS</creatorcontrib><title>5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN</title><description>Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHA31Q3wcPWL9Anx8HSM8vdxcQ3yDHMMcVUI9XNRAHJc_RTCXIPCXf1cQv3cFRx9ghUCDI11vT39HINddT39PDydPEP8gap4GFjTEnOKU3mhNDeDmptriLOHbmpBfnxqcUFicmpeakm8i6uZgZGBgYmBoaGhpWVIiJEx0QoBq_Iu-w</recordid><startdate>20090102</startdate><enddate>20090102</enddate><creator>OZA, MRINALINI S</creator><creator>BRUCE, IAN</creator><creator>BLOOMFIELD, G. C</creator><creator>LEBLANC, CATHERINE</creator><creator>WHITEHEAD, LEWIS</creator><scope>EVB</scope></search><sort><creationdate>20090102</creationdate><title>5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN</title><author>OZA, MRINALINI S ; BRUCE, IAN ; BLOOMFIELD, G. C ; LEBLANC, CATHERINE ; WHITEHEAD, LEWIS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE602004011199TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OZA, MRINALINI S</creatorcontrib><creatorcontrib>BRUCE, IAN</creatorcontrib><creatorcontrib>BLOOMFIELD, G. C</creatorcontrib><creatorcontrib>LEBLANC, CATHERINE</creatorcontrib><creatorcontrib>WHITEHEAD, LEWIS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OZA, MRINALINI S</au><au>BRUCE, IAN</au><au>BLOOMFIELD, G. C</au><au>LEBLANC, CATHERINE</au><au>WHITEHEAD, LEWIS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN</title><date>2009-01-02</date><risdate>2009</risdate><abstract>Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_DE602004011199TT2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 5-PHENYLTHIAZOLDERIVATE UND DEREN VERWENDUNG ALS P13-KINASE-INHIBITOREN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OZA,%20MRINALINI%20S&rft.date=2009-01-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE602004011199TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true